Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis. 1990

U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
Department of Infectious Diseases, Karolinska Institute, Roslagstull Hospital, Stockholm, Sweden.

The plasma concentrations of sulfadoxine, pyrimethamine, mefloquine and its major metabolite were determined in 18 healthy male volunteers who had regularly taken either 500 mg of sulfadoxine and 25 mg of pyrimethamine (Fansidar) weekly or 250 mg mefloquine regularly every 14 d during 6 months for malaria prophylaxis. The mean trough concentrations of sulfadoxine, pyrimethamine and mefloquine were 194, 0.28 and 1.48 mumol/litre and the mean half lives were 7.7, 4.2 and 25 d respectively. The variation in area under the curve for the 3 drugs was only 2-3 fold. The findings do not indicate that drug accumulation or induction of metabolism occurred during long-term usage.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013413 Sulfadoxine A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections. Sulformethoxine,Sulforthomidine,Fanasil,Ro 4-4393,Sulformetoxine,Sulphormetoxin,Sulphorthodimethoxine,Ro 4 4393,Ro 44393

Related Publications

U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
January 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene,
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
January 1987, Bulletin of the World Health Organization,
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
January 1993, Wiener klinische Wochenschrift,
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
January 1985, Lancet (London, England),
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
March 1985, Lancet (London, England),
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
October 1982, Lancet (London, England),
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
April 1982, Lancet (London, England),
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
September 1985, Lancet (London, England),
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
January 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene,
U Hellgren, and V H Angel, and Y Bergqvist, and A Arvidsson, and J S Forero-Gomez, and L Rombo
July 1991, Lancet (London, England),
Copied contents to your clipboard!